Andilum, Baby Girl .
HRN: 21-99-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2022
FLUCONAZOLE 50MG (CAP)
10/18/2022
10/25/2022
PO
4.5 Mg
2 X A Week
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes